Form 4 for ABCL AbCellera Biologics Inc.
Accepted 2025-11-26 00:00:00 ET · period of report 2025-11-26 · accession 0001834423-25-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-26 | 2025-11-26 | ABCL | Montalbano John S. | Dir | P - Purchase | $3.57 | +50.0K | 221.0K | +29% | +$178.5K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2025-11-26 | P | A | 50,000 | $3.57 | 221,000 | D | — | — |